Lunai Bioworks LNAI
NASDAQ LNAI
$2.25 +0.05 (+2.27%)
As of: Aug 21, 2026 · 10:31 AM EDT

Lunai Bioworks (LNAI) EPS (Basic) (2011 - 2026)

Lunai Bioworks (LNAI) posted quarterly EPS (Basic) of -$0.51 for Q1 2026, up 76.34% year-over-year from -$0.29 in Q1 2025, and up 23.42% quarter-over-quarter from -$0.66 in Q4 2025.

Lunai Bioworks (LNAI) EPS (Basic) (2011 - 2026) Analysis & Trends

Lunai Bioworks' EPS (Basic) history runs 16 years deep, the most recent figure standing at -$0.51 for Q1 2026.

  • In Q1 2026, EPS (Basic) rose 76.34% year-over-year to -$0.51; the TTM figure through Mar 2026 stood at -$42.69 (down 9.89% YoY), while the FY2025 annual figure was -$132.14, up 37.07% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$0.51, up from -$0.66 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.51 in Q1 2026, with the low at -$137.43 in Q2 2022.
  • The 5-year median for EPS (Basic) is -$9.42 (2022), against an average of -$21.65.
  • The sharpest annual moves came in 2024 and 2025: EPS (Basic) tumbled 522.43% in 2024, then jumped 95.54% in 2025.
  • Lunai Bioworks' EPS (Basic) stood at -$6.42 in 2022, then rose by 14.06% to -$5.52 in 2023, then surged by 58.41% to -$2.3 in 2024, then jumped by 71.15% to -$0.66 in 2025, then advanced by 23.42% to -$0.51 in 2026.
  • Business Quant data shows LNAI's EPS (Basic) at -$0.51 in Q1 2026, -$0.66 in Q4 2025, and -$1.22 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.65 Bn 131.79 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 86.08 Bn 78.09 Bn 3.93 Bn 12.62
3 Argenx Se 65.16 Bn 59.98 Bn 1.37 Bn 7.59
4 Moderna 63.25 Bn 58.11 Bn 52.00 Mn -1.96
5 BeOne Medicines 42.22 Bn 37.12 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.26 Bn 27.95 Bn 992.69 Mn 1.23
7 BioNTech SE 28.96 Bn 10.57 Bn 668.28 Mn -0.72
8 Insmed 27.40 Bn 26.24 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.19 Bn 26.35 Bn - 0.18
10 Lunai Bioworks 7.03 Mn 3.87 Mn 20,942.00 -0.51

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.51
Dec 31, 2025 -0.66
Sep 30, 2025 -1.22
Jun 30, 2025 -61.26
Mar 31, 2025 -2.14
Dec 31, 2024 -2.30
Sep 30, 2024 -27.32
Jun 30, 2024 -13.60
Mar 31, 2024 -38.50
Dec 31, 2023 -5.52
Sep 30, 2023 -11.38
Jun 30, 2023 -32.98
Mar 31, 2023 -6.19
Dec 31, 2022 -6.42
Sep 30, 2022 -11.18
Jun 30, 2022 -137.43
Mar 31, 2022 -9.42
Dec 31, 2021 -10.07
Sep 30, 2021 -15.95
Jun 30, 2021 -29.45